These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 26418880)

  • 21. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA.
    Kurvinen K; Syrjänen S; Johansson B
    Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells.
    Won J; Yim J; Kim TK
    FASEB J; 2002 Dec; 16(14):1943-5. PubMed ID: 12368233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth.
    Zhang N; Zhang R; Zou K; Yu W; Guo W; Gao Y; Li J; Li M; Tai Y; Huang W; Song C; Deng W; Cui X
    Cell Death Dis; 2017 Jul; 8(7):e2961. PubMed ID: 28749462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
    Kong BH; Song Y; Ma DX; Qu X; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells.
    Luo Y; Yi Y; Yao Z
    Cancer Invest; 2009 Dec; 27(10):960-70. PubMed ID: 19909010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter.
    Koga S; Hirohata S; Kondo Y; Komata T; Takakura M; Inoue M; Kyo S; Kondo S
    Hum Gene Ther; 2000 Jul; 11(10):1397-406. PubMed ID: 10910137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.
    Guilleret I; Yan P; Grange F; Braunschweig R; Bosman FT; Benhattar J
    Int J Cancer; 2002 Oct; 101(4):335-41. PubMed ID: 12209957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of telomerase and its hTERT messenger in colorectal cancer.
    Boldrini L; Faviana P; Gisfredi S; Donati V; Zucconi Y; Ursino S; Simi P; Baldinotti F; Berti P; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
    Oncol Rep; 2004 Feb; 11(2):395-400. PubMed ID: 14719074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
    Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
    Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-specific expression detected with the use of an expression vector driven by human telomerase reverse transcriptase gene promoter.
    Yin J; Fu P; Wang X; Jin G; Xiu R
    J Lab Clin Med; 2004 Dec; 144(6):302-6. PubMed ID: 15614252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDC5L Promotes hTERT Expression and Colorectal Tumor Growth.
    Li J; Zhang N; Zhang R; Sun L; Yu W; Guo W; Gao Y; Li M; Liu W; Liang P; Deng W; Cui X
    Cell Physiol Biochem; 2017; 41(6):2475-2488. PubMed ID: 28472785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells.
    Shen Y; Zhang YW; Zhang ZX; Miao ZH; Ding J
    Cancer Biol Ther; 2008 Feb; 7(2):228-36. PubMed ID: 18059183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
    Kammori M; Kanauchi H; Nakamura K; Kawahara M; Weber TK; Mafune K; Kaminishi M; Takubo K
    Int J Oncol; 2002 Jan; 20(1):15-21. PubMed ID: 11743637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription.
    Endoh T; Tsuji N; Asanuma K; Yagihashi A; Watanabe N
    Exp Cell Res; 2005 May; 305(2):300-11. PubMed ID: 15817155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
    Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas.
    Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW
    Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
    Gu J; Kagawa S; Takakura M; Kyo S; Inoue M; Roth JA; Fang B
    Cancer Res; 2000 Oct; 60(19):5359-64. PubMed ID: 11034071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3.
    Cassar L; Nicholls C; Pinto AR; Li H; Liu JP
    FASEB J; 2009 Jun; 23(6):1880-92. PubMed ID: 19193721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells.
    Toaldo C; Pizzimenti S; Cerbone A; Pettazzoni P; Menegatti E; Daniela B; Minelli R; Giglioni B; Dianzani MU; Ferretti C; Barrera G
    J Cell Mol Med; 2010 Jun; 14(6A):1347-57. PubMed ID: 19912441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of human telomerase reverse transcriptase through anti-C-myc siRNA in human colon cancer Colo 320 cells.
    Hu X; Yu N; Fu L; Su W; Huang G; Wu Y; Huang H; Huang H
    Nucleosides Nucleotides Nucleic Acids; 2009; 28(1):1-11. PubMed ID: 19116866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.